Literature DB >> 12560216

Vasoactivity of S-nitrosohemoglobin: role of oxygen, heme, and NO oxidation states.

Jack H Crawford1, C Roger White, Rakesh P Patel.   

Abstract

The mechanisms by which S-nitrosohemoglobin (SNOHb) stimulates vasodilation are unclear and underlie the controversies surrounding the proposal that this S-nitrosothiol modulates blood flow in vivo. Among the mechanistic complexities are the nature of vasoactive species released from SNOHb and the role heme and oxygen play in this process. This is important to address since hemoglobin inhibits NO-dependent vasodilation. We compared the vasodilatory properties of distinct oxidation and ligation states of SNOHb at different oxygen tensions. The results show that SNOHb in the oxygenated state (SNOoxyHb) is significantly less efficient than SNOHb in the ferric or met oxidation state (SNOmetHb) at stimulating relaxation of isolated rat aortic rings. Using pharmacologic approaches to modulate nitrogen monoxide radical (.NO)-dependent relaxation, our data suggest that SNOoxyHb promotes vasodilation in a.NO-independent manner. In contrast, both SNOmetHb and S-nitrosoglutathione (GSNO), a putative intermediate in SNOHb reactivity, elicit vasodilation in a.NO-dependent process. Consistent with previous observations, an increase in sensitivity of SNOHb vasodilation at low oxygen tensions also was observed. However, this was not exclusive for this protein but applied to a range of nitrosovasodilators (including a.NO donor [DeaNonoate], an S-nitrosothiol [GSNO], and the nitroxyl anion donor, Angelis salt). This suggests that oxygen-dependent modulation of SNOHb vasoactivity does not occur by controlling the allosteric state of Hb but is a property of vessel responsiveness to nitrosovasodilators at low oxygen tensions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560216     DOI: 10.1182/blood-2002-12-3825

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  The functional nitrite reductase activity of the heme-globins.

Authors:  Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

Review 2.  Effect of processing and storage on red blood cell function in vivo.

Authors:  Allan Doctor; Phil Spinella
Journal:  Semin Perinatol       Date:  2012-08       Impact factor: 3.300

3.  Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver.

Authors:  Mark R Duranski; James J M Greer; Andre Dejam; Sathya Jaganmohan; Neil Hogg; William Langston; Rakesh P Patel; Shaw-Fang Yet; Xunde Wang; Christopher G Kevil; Mark T Gladwin; David J Lefer
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

4.  Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation.

Authors:  Jack H Crawford; T Scott Isbell; Zhi Huang; Sruti Shiva; Balu K Chacko; Alan N Schechter; Victor M Darley-Usmar; Jeffrey D Kerby; John D Lang; David Kraus; Chien Ho; Mark T Gladwin; Rakesh P Patel
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

5.  Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties.

Authors:  Mai E Shoman; Jenna F DuMond; T S Isbell; J H Crawford; Angela Brandon; Jaideep Honovar; Dario A Vitturi; C R White; R P Patel; S Bruce King
Journal:  J Med Chem       Date:  2011-01-19       Impact factor: 7.446

6.  Antioxidant functions for the hemoglobin β93 cysteine residue in erythrocytes and in the vascular compartment in vivo.

Authors:  Dario A Vitturi; Chiao-Wang Sun; Victoria M Harper; Bessy Thrash-Williams; Nadiezhda Cantu-Medellin; Balu K Chacko; Ning Peng; Yanying Dai; J Michael Wyss; Tim Townes; Rakesh P Patel
Journal:  Free Radic Biol Med       Date:  2012-11-16       Impact factor: 7.376

Review 7.  Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?

Authors:  Corinna Lupp; Silke Baasner; Can Ince; Frank Nocken; John F Stover; Martin Westphal
Journal:  Crit Care       Date:  2013-05-29       Impact factor: 9.097

8.  Erythrocytes do not activate purified and platelet soluble guanylate cyclases even in conditions favourable for NO synthesis.

Authors:  Stepan Gambaryan; Hariharan Subramanian; Linda Kehrer; Igor Mindukshev; Julia Sudnitsyna; Cora Reiss; Natalia Rukoyatkina; Andreas Friebe; Iraida Sharina; Emil Martin; Ulrich Walter
Journal:  Cell Commun Signal       Date:  2016-08-11       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.